AU2002224003A1 - Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering - Google Patents
Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineeringInfo
- Publication number
- AU2002224003A1 AU2002224003A1 AU2002224003A AU2400302A AU2002224003A1 AU 2002224003 A1 AU2002224003 A1 AU 2002224003A1 AU 2002224003 A AU2002224003 A AU 2002224003A AU 2400302 A AU2400302 A AU 2400302A AU 2002224003 A1 AU2002224003 A1 AU 2002224003A1
- Authority
- AU
- Australia
- Prior art keywords
- biological matrices
- tissue engineering
- decellularizing
- acellular
- useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL139708 | 2000-11-15 | ||
IL13970800A IL139708A0 (en) | 2000-11-15 | 2000-11-15 | Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering |
PCT/IL2001/001060 WO2002040630A2 (en) | 2000-11-15 | 2001-11-15 | Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002224003A1 true AU2002224003A1 (en) | 2002-05-27 |
Family
ID=11074822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002224003A Abandoned AU2002224003A1 (en) | 2000-11-15 | 2001-11-15 | Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002224003A1 (en) |
IL (1) | IL139708A0 (en) |
WO (1) | WO2002040630A2 (en) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4092397B2 (en) * | 2002-09-10 | 2008-05-28 | 国立循環器病センター総長 | Treatment of living tissue for transplantation by applying ultrahigh hydrostatic pressure |
US7459154B2 (en) * | 2002-12-26 | 2008-12-02 | Cell Genesys, Inc. | Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
CA2536923C (en) | 2003-09-04 | 2012-10-09 | Cook Biotech Incorporated | Extracellular matrix composite materials, and manufacture and use thereof |
DE602005022491D1 (en) * | 2005-01-05 | 2010-09-02 | Cleveland Clinic Foundation | PROCESS FOR FIXING TISSUE |
WO2006102063A2 (en) | 2005-03-19 | 2006-09-28 | Cook Biotech Incorporated | Prosthetic implants including ecm composite material |
WO2006113382A2 (en) * | 2005-04-15 | 2006-10-26 | Wake Forest University Health Sciences | Bioreactor system and method of enhancing functionality of muscle cultured in vitro |
EP1719533A1 (en) * | 2005-05-04 | 2006-11-08 | Tecnobiomedica S.p.A. | Method of preparing acellularized, biocompatible, implantable material |
US9072816B2 (en) * | 2006-01-18 | 2015-07-07 | Cormatrix Cardiovascular, Inc. | Composition for modulating inflammation of cardiovascular tissue |
US8568761B2 (en) * | 2005-07-15 | 2013-10-29 | Cormatrix Cardiovascular, Inc. | Compositions for regenerating defective or absent myocardium |
ATE552007T1 (en) | 2005-08-26 | 2012-04-15 | Univ Minnesota | DECELLULARIZATION AND RECELLULARIZATION OF ORGANS AND TISSUES |
US9211307B2 (en) * | 2005-11-08 | 2015-12-15 | Georgia Tech Research Corporation | Acellularized biomaterial from embryonic stem cells |
US20160082153A1 (en) * | 2006-01-18 | 2016-03-24 | Cormatrix Cardiovascular, Inc. | Method and System for Treatment of Damaged Biological Tissue |
GB0606231D0 (en) | 2006-03-29 | 2006-05-10 | Univ Leeds | Improvements relating to decellurisation of tissue matrices for bladder implantation |
CN104623643A (en) | 2006-10-06 | 2015-05-20 | 人类起源公司 | Natural (telopeptide) placental collagen compositions |
AU2013203211B2 (en) * | 2006-10-06 | 2015-05-28 | Celularity Inc. | Native (telopeptide) placental collagen compositions |
CN101616698A (en) | 2006-10-23 | 2009-12-30 | 库克生物科技公司 | The ECM material of the enhanced processing of component characteristic |
CZ301086B6 (en) * | 2007-10-17 | 2009-11-04 | Bio-Skin, A. S. | Sterile autogenous, allogenic or xenogenic implant and process for preparing thereof |
TWI432230B (en) * | 2008-08-14 | 2014-04-01 | Kci Licensing Inc | Tissue scaffolds |
PL2588592T3 (en) * | 2010-06-30 | 2018-07-31 | Miromatrix Medical Inc. | Use of perfusion decellularized organs for matched recellularization |
WO2012031162A1 (en) | 2010-09-01 | 2012-03-08 | Doris Taylor | Methods of recellularizing a tissue or organ for improved transplantability |
US20130013083A1 (en) * | 2011-01-06 | 2013-01-10 | Humacyte | Tissue-Engineered Constructs |
CA2822689C (en) | 2011-01-06 | 2015-12-29 | Humacyte | Tissue-engineered constructs |
WO2012166784A1 (en) | 2011-05-31 | 2012-12-06 | Lifecell Corporation | Adipose tissue matrices |
JP6335792B2 (en) * | 2012-01-16 | 2018-05-30 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Determining the presence of target molecules in body fluids containing cells |
ES2716993T3 (en) | 2012-03-08 | 2019-06-18 | Lifecell Corp | Matrices of collagen and tissue activated by enzymes |
US9290738B2 (en) | 2012-06-13 | 2016-03-22 | Miromatrix Medical Inc. | Methods of decellularizing bone |
ES2676043T3 (en) | 2012-07-05 | 2018-07-16 | Lifecell Corporation | Tissue Drainage Collectors |
CN103536967B (en) * | 2012-07-10 | 2016-04-13 | 上海微创医疗器械(集团)有限公司 | A kind of method for removing cells preparing extracellular matrix support material |
ES2753156T3 (en) | 2012-07-13 | 2020-04-07 | Lifecell Corp | Improved adipose tissue treatment procedures |
WO2014052376A1 (en) | 2012-09-26 | 2014-04-03 | Lifecell Corporation | Processed adipose tissue |
US10035980B2 (en) | 2013-01-14 | 2018-07-31 | Florida State University Research Foundation, Inc. | Extracellular matrix derived from stem cells and methods for production |
EP2970891B1 (en) | 2013-03-15 | 2020-10-21 | Miromatrix Medical Inc. | Use of perfusion decellularized liver for islet cell recellularization |
CN104353115B (en) * | 2014-10-29 | 2016-06-01 | 南通大学附属医院 | Take off the test kit of cytoskeleton, the preparation of support for pancreas and plant method for planting again |
CN105013014A (en) * | 2015-07-31 | 2015-11-04 | 武汉蓝普医品有限公司 | Preparation method and application of acellular matrix biological material |
CN105920670A (en) * | 2016-05-19 | 2016-09-07 | 李世荣 | Degradable male genital organ patch composite material with biological elasticity and preparation method thereof |
JP7084320B2 (en) | 2016-06-15 | 2022-06-14 | ザ ジェネラル ホスピタル コーポレイション | Metabolic labeling and molecular enhancement of biomaterials using bioorthogonal reactions |
AU2017292652B2 (en) | 2016-07-05 | 2022-03-24 | Lifecell Corporation | Tissue matrices incorporating multiple tissue types |
US11278643B2 (en) | 2016-09-06 | 2022-03-22 | Mayo Foundation For Medical Education And Research | Use of resected liver serum for whole liver-engineering |
KR20200016226A (en) * | 2017-05-30 | 2020-02-14 | 가부시키가이샤 아데카 | Method for producing a decellularized material for transplantation and graft composition comprising a biocompatible material comprising the material |
CN107596446B (en) * | 2017-09-16 | 2020-07-28 | 温州医科大学 | Decellularization kit for maintaining tissue ultrastructure and nutrition microenvironment |
CA3075099A1 (en) | 2017-10-18 | 2019-04-25 | Lifecell Corporation | Adipose tissue products and methods of production |
US11123375B2 (en) | 2017-10-18 | 2021-09-21 | Lifecell Corporation | Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products |
US11246994B2 (en) | 2017-10-19 | 2022-02-15 | Lifecell Corporation | Methods for introduction of flowable acellular tissue matrix products into a hand |
WO2019079672A1 (en) | 2017-10-19 | 2019-04-25 | Lifecell Corporation | Flowable acellular tissue matrix products and methods of production |
CN110876816A (en) * | 2018-09-06 | 2020-03-13 | 韩嫣 | Pig bladder source bioactive repair material |
JP2022534110A (en) | 2019-05-30 | 2022-07-27 | ライフセル コーポレーション | biological breast implants |
CN111569151B (en) * | 2020-05-12 | 2021-12-17 | 上海亚朋生物技术有限公司 | Acellular dermal matrix tissue engineering scaffold and preparation method thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8618374D0 (en) * | 1986-07-28 | 1986-09-03 | Hsc Res Dev Corp | Biological vascular prostheses |
US5735902A (en) * | 1987-07-20 | 1998-04-07 | Regen Biologics, Inc. | Hand implant device |
US5681353A (en) * | 1987-07-20 | 1997-10-28 | Regen Biologics, Inc. | Meniscal augmentation device |
JPH06505187A (en) * | 1991-02-14 | 1994-06-16 | バクスター インターナショナル インコーポレーテッド | Flexible biograft material and method for manufacturing the same |
AU5564996A (en) * | 1995-04-19 | 1996-11-07 | St. Jude Medical Inc. | Matrix substrate for a viable body tissue-derived prosthesis and method for making the same |
US6376244B1 (en) * | 1999-12-29 | 2002-04-23 | Children's Medical Center Corporation | Methods and compositions for organ decellularization |
-
2000
- 2000-11-15 IL IL13970800A patent/IL139708A0/en unknown
-
2001
- 2001-11-15 AU AU2002224003A patent/AU2002224003A1/en not_active Abandoned
- 2001-11-15 WO PCT/IL2001/001060 patent/WO2002040630A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002040630A2 (en) | 2002-05-23 |
WO2002040630A3 (en) | 2004-06-10 |
IL139708A0 (en) | 2002-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002224003A1 (en) | Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering | |
AU8657601A (en) | Composition and method for treatment of hypertriglyceridemia | |
AU2001236002A1 (en) | Method and apparatus for culturing cell or tissue | |
HK1048949A1 (en) | Method and composition for the treatment of scars | |
AU2002340807A1 (en) | Method for the devitalisation of natural organs and/or for the preparation of extracellular matrices for tissue engineering | |
AU2001260847A1 (en) | Compositions isolated from skin cells and methods for their use | |
EP1416044A4 (en) | Support for cell / tissue culture and culture method | |
AU2001287023A1 (en) | Plasma-derived-fibrin-based matrices and tissue | |
AU2001255767A1 (en) | Methods and reagents for tissue engineering of cartilage in vitro | |
HK1047250A1 (en) | Tissue augmentation material and methods | |
AUPR211400A0 (en) | Material and method for treatment of timber | |
AU2001274181A1 (en) | Composition and method for biocide treatment of surfaces | |
AU2001292917A1 (en) | Method of preparing and processing transplant tissue | |
AU2786100A (en) | Method of selecting transformed cells and tissues | |
WO2001091700A8 (en) | Composition and method for enhancing elasticity of tissue | |
AU2002230459A1 (en) | Cell culture apparatus and methods of use | |
AU3205801A (en) | Method and composition for promoting hair growth | |
AU2001234831A1 (en) | Magnetoliposome composition for targeted treatment of biological tissue and associated methods | |
AU2001246763A1 (en) | A preparation method for a porous framework used in the prostheses of tissue andorgans | |
AU2001217686A1 (en) | Method of establishing cultures of human dendritic cells and use thereof | |
IL130968A0 (en) | Pharmaceutical composition useful for the treatment of tinnitus and hearing loss | |
AU2000240061A1 (en) | Tissue compositions using cultured fibroblasts and keratinocytes and methods of use thereof | |
AU2002230479A1 (en) | Cell culture apparatus and methods of use | |
AU2001280299A1 (en) | Improvements in and relating to methods and apparatus for the application of honey to wounds | |
AU2002241691A1 (en) | Biologically active composites and methods for their production and use |